Retatrutide
Retatrutide is a novel triple agonist peptide that activates GIP, GLP-1, and glucagon receptors. Research indicates potential applications in metabolic studies and energy expenditure research.
What This Compound Is
Retatrutide is an innovative triple receptor agonist that simultaneously activates GIP, GLP-1, and glucagon receptors. This unique triple mechanism distinguishes it from dual agonists in metabolic research. Scientists study this compound to understand how combined receptor activation affects metabolic processes, energy balance, and cellular signaling pathways in laboratory models.
Research Interest
Research on Retatrutide focuses on its triple agonist mechanism and how it influences metabolic regulation. Studies examine the synergistic effects of GIP, GLP-1, and glucagon receptor activation on energy expenditure, thermogenesis, fat oxidation, and glucose metabolism. Researchers investigate its impact on hepatic function, adipose tissue dynamics, and mitochondrial activity in various experimental settings.
Educational Disclaimer
For laboratory research purposes only. Not for human consumption or clinical use. This product is intended solely for in-vitro research and educational applications.
Available Formats
Related Research Compounds
Explore similar peptides and compounds that researchers often study together